世界の女性用避妊薬市場:販売動向2018

【英語タイトル】Global Female Contraception Drug Sales Market Report 2018

QYResearchが出版した調査資料(QYR8020660)・商品コード:QYR8020660
・発行会社(調査会社):QYResearch
・発行日:2017年12月29日
・ページ数:109
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥460,000見積依頼/購入/質問フォーム
Enterprise(同一法人内共有可)USD8,000 ⇒換算¥920,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポート(2018年版)では、女性用避妊薬の世界市場について調査・分析し、女性用避妊薬のメーカー別販売量、市場シェア分析、種類別販売分析、用途別販売分析、地域別販売分析(アメリカ、中国、ヨーロッパ、日本、東南アジア、インド)、価格動向、企業動向、女性用避妊薬産業チェーン分析、世界市場規模予測などを含め、以下の構成でお届けいたします。

・女性用避妊薬市場概要
・女性用避妊薬のメーカー別販売量・メーカー別シェア
・女性用避妊薬の世界市場:種類別販売量・市場シェア
・女性用避妊薬の世界市場:用途別販売量・市場シェア
・女性用避妊薬の世界市場:地域別販売量・市場シェア
・女性用避妊薬のアメリカ市場規模
・女性用避妊薬の中国市場規模
・女性用避妊薬のヨーロッパ市場規模
・女性用避妊薬の日本市場規模
・女性用避妊薬の東南アジア市場規模
・女性用避妊薬のインド市場規模
・女性用避妊薬のメーカー別分析(企業概要、事業概要、製品概要、収益、価格等)
・女性用避妊薬のコスト分析・価格動向
・女性用避妊薬の産業チェーン(サプライチェーン分析)
・女性用避妊薬のマーケティング戦略・販売チャネル、流通業者
・女性用避妊薬市場への影響要因分析
・女性用避妊薬の世界市場予測
・女性用避妊薬のアメリカ市場予測
・女性用避妊薬の中国市場予測
・女性用避妊薬のヨーロッパ市場予測
・女性用避妊薬の日本市場予測
・女性用避妊薬の東南アジア市場予測
・女性用避妊薬のインド市場予測
・女性用避妊薬の種類別世界市場予測
・女性用避妊薬の用途別世界市場予測
...
【レポートの概要】

In this report, the global Female Contraception Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Female Contraception Drug for these regions, from 2012 to 2022 (forecast), covering
United States
China
Europe
Japan
Southeast Asia
India

Global Female Contraception Drug market competition by top manufacturers/players, with Female Contraception Drug sales volume, Price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
Addex Therapeutics Ltd
Agile Therapeutics Inc
Bayer AG
Evofem Inc
Hervana Ltd
Mithra Pharmaceuticals SA
Orbis Biosciences Inc
Teva Pharmaceutical Industries Ltd
Viramal Ltd
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
AG-890
Amphora
BAY-1007626
Drospirenone
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Clinic
Hospital
Homecare

If you have any special requirements, please let us know and we will offer you the report as you want.

【レポートの目次】

Table of Contents

Global Female Contraception Drug Sales Market Report 2017
1 Female Contraception Drug Market Overview
1.1 Product Overview and Scope of Female Contraception Drug
1.2 Classification of Female Contraception Drug by Product Category
1.2.1 Global Female Contraception Drug Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 Global Female Contraception Drug Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 AG-890
1.2.4 Amphora
1.2.5 BAY-1007626
1.2.6 Drospirenone
1.2.7 Others
1.3 Global Female Contraception Drug Market by Application/End Users
1.3.1 Global Female Contraception Drug Sales (Volume) and Market Share Comparison by Application (2012-2022)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Homecare
1.4 Global Female Contraception Drug Market by Region
1.4.1 Global Female Contraception Drug Market Size (Value) Comparison by Region (2012-2022)
1.4.2 United States Female Contraception Drug Status and Prospect (2012-2022)
1.4.3 China Female Contraception Drug Status and Prospect (2012-2022)
1.4.4 Europe Female Contraception Drug Status and Prospect (2012-2022)
1.4.5 Japan Female Contraception Drug Status and Prospect (2012-2022)
1.4.6 Southeast Asia Female Contraception Drug Status and Prospect (2012-2022)
1.4.7 India Female Contraception Drug Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Female Contraception Drug (2012-2022)
1.5.1 Global Female Contraception Drug Sales and Growth Rate (2012-2022)
1.5.2 Global Female Contraception Drug Revenue and Growth Rate (2012-2022)

2 Global Female Contraception Drug Competition by Players/Suppliers, Type and Application
2.1 Global Female Contraception Drug Market Competition by Players/Suppliers
2.1.1 Global Female Contraception Drug Sales and Market Share of Key Players/Suppliers (2012-2017)
2.1.2 Global Female Contraception Drug Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global Female Contraception Drug (Volume and Value) by Type
2.2.1 Global Female Contraception Drug Sales and Market Share by Type (2012-2017)
2.2.2 Global Female Contraception Drug Revenue and Market Share by Type (2012-2017)
2.3 Global Female Contraception Drug (Volume and Value) by Region
2.3.1 Global Female Contraception Drug Sales and Market Share by Region (2012-2017)
2.3.2 Global Female Contraception Drug Revenue and Market Share by Region (2012-2017)
2.4 Global Female Contraception Drug (Volume) by Application

3 United States Female Contraception Drug (Volume, Value and Sales Price)
3.1 United States Female Contraception Drug Sales and Value (2012-2017)
3.1.1 United States Female Contraception Drug Sales and Growth Rate (2012-2017)
3.1.2 United States Female Contraception Drug Revenue and Growth Rate (2012-2017)
3.1.3 United States Female Contraception Drug Sales Price Trend (2012-2017)
3.2 United States Female Contraception Drug Sales Volume and Market Share by Players
3.3 United States Female Contraception Drug Sales Volume and Market Share by Type
3.4 United States Female Contraception Drug Sales Volume and Market Share by Application

4 China Female Contraception Drug (Volume, Value and Sales Price)
4.1 China Female Contraception Drug Sales and Value (2012-2017)
4.1.1 China Female Contraception Drug Sales and Growth Rate (2012-2017)
4.1.2 China Female Contraception Drug Revenue and Growth Rate (2012-2017)
4.1.3 China Female Contraception Drug Sales Price Trend (2012-2017)
4.2 China Female Contraception Drug Sales Volume and Market Share by Players
4.3 China Female Contraception Drug Sales Volume and Market Share by Type
4.4 China Female Contraception Drug Sales Volume and Market Share by Application

5 Europe Female Contraception Drug (Volume, Value and Sales Price)
5.1 Europe Female Contraception Drug Sales and Value (2012-2017)
5.1.1 Europe Female Contraception Drug Sales and Growth Rate (2012-2017)
5.1.2 Europe Female Contraception Drug Revenue and Growth Rate (2012-2017)
5.1.3 Europe Female Contraception Drug Sales Price Trend (2012-2017)
5.2 Europe Female Contraception Drug Sales Volume and Market Share by Players
5.3 Europe Female Contraception Drug Sales Volume and Market Share by Type
5.4 Europe Female Contraception Drug Sales Volume and Market Share by Application

6 Japan Female Contraception Drug (Volume, Value and Sales Price)
6.1 Japan Female Contraception Drug Sales and Value (2012-2017)
6.1.1 Japan Female Contraception Drug Sales and Growth Rate (2012-2017)
6.1.2 Japan Female Contraception Drug Revenue and Growth Rate (2012-2017)
6.1.3 Japan Female Contraception Drug Sales Price Trend (2012-2017)
6.2 Japan Female Contraception Drug Sales Volume and Market Share by Players
6.3 Japan Female Contraception Drug Sales Volume and Market Share by Type
6.4 Japan Female Contraception Drug Sales Volume and Market Share by Application

7 Southeast Asia Female Contraception Drug (Volume, Value and Sales Price)
7.1 Southeast Asia Female Contraception Drug Sales and Value (2012-2017)
7.1.1 Southeast Asia Female Contraception Drug Sales and Growth Rate (2012-2017)
7.1.2 Southeast Asia Female Contraception Drug Revenue and Growth Rate (2012-2017)
7.1.3 Southeast Asia Female Contraception Drug Sales Price Trend (2012-2017)
7.2 Southeast Asia Female Contraception Drug Sales Volume and Market Share by Players
7.3 Southeast Asia Female Contraception Drug Sales Volume and Market Share by Type
7.4 Southeast Asia Female Contraception Drug Sales Volume and Market Share by Application

8 India Female Contraception Drug (Volume, Value and Sales Price)
8.1 India Female Contraception Drug Sales and Value (2012-2017)
8.1.1 India Female Contraception Drug Sales and Growth Rate (2012-2017)
8.1.2 India Female Contraception Drug Revenue and Growth Rate (2012-2017)
8.1.3 India Female Contraception Drug Sales Price Trend (2012-2017)
8.2 India Female Contraception Drug Sales Volume and Market Share by Players
8.3 India Female Contraception Drug Sales Volume and Market Share by Type
8.4 India Female Contraception Drug Sales Volume and Market Share by Application

9 Global Female Contraception Drug Players/Suppliers Profiles and Sales Data
9.1 Addex Therapeutics Ltd
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Female Contraception Drug Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Addex Therapeutics Ltd Female Contraception Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 Agile Therapeutics Inc
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Female Contraception Drug Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Agile Therapeutics Inc Female Contraception Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 Bayer AG
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Female Contraception Drug Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Bayer AG Female Contraception Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 Evofem Inc
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Female Contraception Drug Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Evofem Inc Female Contraception Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
9.5 Hervana Ltd
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Female Contraception Drug Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Hervana Ltd Female Contraception Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.5.4 Main Business/Business Overview
9.6 Mithra Pharmaceuticals SA
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Female Contraception Drug Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Mithra Pharmaceuticals SA Female Contraception Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.6.4 Main Business/Business Overview
9.7 Orbis Biosciences Inc
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Female Contraception Drug Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Orbis Biosciences Inc Female Contraception Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.7.4 Main Business/Business Overview
9.8 Teva Pharmaceutical Industries Ltd
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Female Contraception Drug Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Teva Pharmaceutical Industries Ltd Female Contraception Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.8.4 Main Business/Business Overview
9.9 Viramal Ltd
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Female Contraception Drug Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Viramal Ltd Female Contraception Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.9.4 Main Business/Business Overview

10 Female Contraception Drug Maufacturing Cost Analysis
10.1 Female Contraception Drug Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Female Contraception Drug
10.3 Manufacturing Process Analysis of Female Contraception Drug

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Female Contraception Drug Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Female Contraception Drug Major Manufacturers in 2016
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Female Contraception Drug Market Forecast (2017-2022)
14.1 Global Female Contraception Drug Sales Volume, Revenue and Price Forecast (2017-2022)
14.1.1 Global Female Contraception Drug Sales Volume and Growth Rate Forecast (2017-2022)
14.1.2 Global Female Contraception Drug Revenue and Growth Rate Forecast (2017-2022)
14.1.3 Global Female Contraception Drug Price and Trend Forecast (2017-2022)
14.2 Global Female Contraception Drug Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
14.2.1 Global Female Contraception Drug Sales Volume and Growth Rate Forecast by Regions (2017-2022)
14.2.2 Global Female Contraception Drug Revenue and Growth Rate Forecast by Regions (2017-2022)
14.2.3 United States Female Contraception Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.4 China Female Contraception Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.5 Europe Female Contraception Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.6 Japan Female Contraception Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.7 Southeast Asia Female Contraception Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.8 India Female Contraception Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Female Contraception Drug Sales Volume, Revenue and Price Forecast by Type (2017-2022)
14.3.1 Global Female Contraception Drug Sales Forecast by Type (2017-2022)
14.3.2 Global Female Contraception Drug Revenue Forecast by Type (2017-2022)
14.3.3 Global Female Contraception Drug Price Forecast by Type (2017-2022)
14.4 Global Female Contraception Drug Sales Volume Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer

List of Tables and Figures

Figure Product Picture of Female Contraception Drug
Figure Global Female Contraception Drug Sales Volume Comparison (K Pcs) by Type (2012-2022)
Figure Global Female Contraception Drug Sales Volume Market Share by Type (Product Category) in 2016
Figure AG-890 Product Picture
Figure Amphora Product Picture
Figure BAY-1007626 Product Picture
Figure Drospirenone Product Picture
Figure Others Product Picture
Figure Global Female Contraception Drug Sales Comparison (K Pcs) by Application (2012-2022)
Figure Global Sales Market Share of Female Contraception Drug by Application in 2016
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Homecare Examples
Table Key Downstream Customer in Homecare
Figure Global Female Contraception Drug Market Size (Million USD) by Regions (2012-2022)
Figure United States Female Contraception Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Female Contraception Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Female Contraception Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Female Contraception Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Female Contraception Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Female Contraception Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Female Contraception Drug Sales Volume (K Pcs) and Growth Rate (2012-2022)
Figure Global Female Contraception Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Market Major Players Female Contraception Drug Sales Volume (K Pcs) (2012-2017)
Table Global Female Contraception Drug Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table Global Female Contraception Drug Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Female Contraception Drug Sales Share by Players/Suppliers
Figure 2017 Female Contraception Drug Sales Share by Players/Suppliers
Figure Global Female Contraception Drug Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Female Contraception Drug Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Female Contraception Drug Revenue Share by Players/Suppliers (2012-2017)
Table 2016 Global Female Contraception Drug Revenue Share by Players
Table 2017 Global Female Contraception Drug Revenue Share by Players
Table Global Female Contraception Drug Sales (K Pcs) and Market Share by Type (2012-2017)
Table Global Female Contraception Drug Sales Share (K Pcs) by Type (2012-2017)
Figure Sales Market Share of Female Contraception Drug by Type (2012-2017)
Figure Global Female Contraception Drug Sales Growth Rate by Type (2012-2017)
Table Global Female Contraception Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table Global Female Contraception Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Female Contraception Drug by Type (2012-2017)
Figure Global Female Contraception Drug Revenue Growth Rate by Type (2012-2017)
Table Global Female Contraception Drug Sales Volume (K Pcs) and Market Share by Region (2012-2017)
Table Global Female Contraception Drug Sales Share by Region (2012-2017)
Figure Sales Market Share of Female Contraception Drug by Region (2012-2017)
Figure Global Female Contraception Drug Sales Growth Rate by Region in 2016
Table Global Female Contraception Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Female Contraception Drug Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Female Contraception Drug by Region (2012-2017)
Figure Global Female Contraception Drug Revenue Growth Rate by Region in 2016
Table Global Female Contraception Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Female Contraception Drug Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Female Contraception Drug by Region (2012-2017)
Figure Global Female Contraception Drug Revenue Market Share by Region in 2016
Table Global Female Contraception Drug Sales Volume (K Pcs) and Market Share by Application (2012-2017)
Table Global Female Contraception Drug Sales Share (%) by Application (2012-2017)
Figure Sales Market Share of Female Contraception Drug by Application (2012-2017)
Figure Global Female Contraception Drug Sales Market Share by Application (2012-2017)
Figure United States Female Contraception Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure United States Female Contraception Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure United States Female Contraception Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table United States Female Contraception Drug Sales Volume (K Pcs) by Players (2012-2017)
Table United States Female Contraception Drug Sales Volume Market Share by Players (2012-2017)
Figure United States Female Contraception Drug Sales Volume Market Share by Players in 2016
Table United States Female Contraception Drug Sales Volume (K Pcs) by Type (2012-2017)
Table United States Female Contraception Drug Sales Volume Market Share by Type (2012-2017)
Figure United States Female Contraception Drug Sales Volume Market Share by Type in 2016
Table United States Female Contraception Drug Sales Volume (K Pcs) by Application (2012-2017)
Table United States Female Contraception Drug Sales Volume Market Share by Application (2012-2017)
Figure United States Female Contraception Drug Sales Volume Market Share by Application in 2016
Figure China Female Contraception Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure China Female Contraception Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Female Contraception Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table China Female Contraception Drug Sales Volume (K Pcs) by Players (2012-2017)
Table China Female Contraception Drug Sales Volume Market Share by Players (2012-2017)
Figure China Female Contraception Drug Sales Volume Market Share by Players in 2016
Table China Female Contraception Drug Sales Volume (K Pcs) by Type (2012-2017)
Table China Female Contraception Drug Sales Volume Market Share by Type (2012-2017)
Figure China Female Contraception Drug Sales Volume Market Share by Type in 2016
Table China Female Contraception Drug Sales Volume (K Pcs) by Application (2012-2017)
Table China Female Contraception Drug Sales Volume Market Share by Application (2012-2017)
Figure China Female Contraception Drug Sales Volume Market Share by Application in 2016
Figure Europe Female Contraception Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Female Contraception Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Europe Female Contraception Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table Europe Female Contraception Drug Sales Volume (K Pcs) by Players (2012-2017)
Table Europe Female Contraception Drug Sales Volume Market Share by Players (2012-2017)
Figure Europe Female Contraception Drug Sales Volume Market Share by Players in 2016
Table Europe Female Contraception Drug Sales Volume (K Pcs) by Type (2012-2017)
Table Europe Female Contraception Drug Sales Volume Market Share by Type (2012-2017)
Figure Europe Female Contraception Drug Sales Volume Market Share by Type in 2016
Table Europe Female Contraception Drug Sales Volume (K Pcs) by Application (2012-2017)
Table Europe Female Contraception Drug Sales Volume Market Share by Application (2012-2017)
Figure Europe Female Contraception Drug Sales Volume Market Share by Application in 2016
Figure Japan Female Contraception Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Japan Female Contraception Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Female Contraception Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table Japan Female Contraception Drug Sales Volume (K Pcs) by Players (2012-2017)
Table Japan Female Contraception Drug Sales Volume Market Share by Players (2012-2017)
Figure Japan Female Contraception Drug Sales Volume Market Share by Players in 2016
Table Japan Female Contraception Drug Sales Volume (K Pcs) by Type (2012-2017)
Table Japan Female Contraception Drug Sales Volume Market Share by Type (2012-2017)
Figure Japan Female Contraception Drug Sales Volume Market Share by Type in 2016
Table Japan Female Contraception Drug Sales Volume (K Pcs) by Application (2012-2017)
Table Japan Female Contraception Drug Sales Volume Market Share by Application (2012-2017)
Figure Japan Female Contraception Drug Sales Volume Market Share by Application in 2016
Figure Southeast Asia Female Contraception Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Southeast Asia Female Contraception Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Female Contraception Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table Southeast Asia Female Contraception Drug Sales Volume (K Pcs) by Players (2012-2017)
Table Southeast Asia Female Contraception Drug Sales Volume Market Share by Players (2012-2017)
Figure Southeast Asia Female Contraception Drug Sales Volume Market Share by Players in 2016
Table Southeast Asia Female Contraception Drug Sales Volume (K Pcs) by Type (2012-2017)
Table Southeast Asia Female Contraception Drug Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Female Contraception Drug Sales Volume Market Share by Type in 2016
Table Southeast Asia Female Contraception Drug Sales Volume (K Pcs) by Application (2012-2017)
Table Southeast Asia Female Contraception Drug Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Female Contraception Drug Sales Volume Market Share by Application in 2016
Figure India Female Contraception Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure India Female Contraception Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Female Contraception Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table India Female Contraception Drug Sales Volume (K Pcs) by Players (2012-2017)
Table India Female Contraception Drug Sales Volume Market Share by Players (2012-2017)
Figure India Female Contraception Drug Sales Volume Market Share by Players in 2016
Table India Female Contraception Drug Sales Volume (K Pcs) by Type (2012-2017)
Table India Female Contraception Drug Sales Volume Market Share by Type (2012-2017)
Figure India Female Contraception Drug Sales Volume Market Share by Type in 2016
Table India Female Contraception Drug Sales Volume (K Pcs) by Application (2012-2017)
Table India Female Contraception Drug Sales Volume Market Share by Application (2012-2017)
Figure India Female Contraception Drug Sales Volume Market Share by Application in 2016
Table Addex Therapeutics Ltd Basic Information List
Table Addex Therapeutics Ltd Female Contraception Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Addex Therapeutics Ltd Female Contraception Drug Sales Growth Rate (2012-2017)
Figure Addex Therapeutics Ltd Female Contraception Drug Sales Global Market Share (2012-2017
Figure Addex Therapeutics Ltd Female Contraception Drug Revenue Global Market Share (2012-2017)
Table Agile Therapeutics Inc Basic Information List
Table Agile Therapeutics Inc Female Contraception Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Agile Therapeutics Inc Female Contraception Drug Sales Growth Rate (2012-2017)
Figure Agile Therapeutics Inc Female Contraception Drug Sales Global Market Share (2012-2017
Figure Agile Therapeutics Inc Female Contraception Drug Revenue Global Market Share (2012-2017)
Table Bayer AG Basic Information List
Table Bayer AG Female Contraception Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bayer AG Female Contraception Drug Sales Growth Rate (2012-2017)
Figure Bayer AG Female Contraception Drug Sales Global Market Share (2012-2017
Figure Bayer AG Female Contraception Drug Revenue Global Market Share (2012-2017)
Table Evofem Inc Basic Information List
Table Evofem Inc Female Contraception Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Evofem Inc Female Contraception Drug Sales Growth Rate (2012-2017)
Figure Evofem Inc Female Contraception Drug Sales Global Market Share (2012-2017
Figure Evofem Inc Female Contraception Drug Revenue Global Market Share (2012-2017)
Table Hervana Ltd Basic Information List
Table Hervana Ltd Female Contraception Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Hervana Ltd Female Contraception Drug Sales Growth Rate (2012-2017)
Figure Hervana Ltd Female Contraception Drug Sales Global Market Share (2012-2017
Figure Hervana Ltd Female Contraception Drug Revenue Global Market Share (2012-2017)
Table Mithra Pharmaceuticals SA Basic Information List
Table Mithra Pharmaceuticals SA Female Contraception Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Mithra Pharmaceuticals SA Female Contraception Drug Sales Growth Rate (2012-2017)
Figure Mithra Pharmaceuticals SA Female Contraception Drug Sales Global Market Share (2012-2017
Figure Mithra Pharmaceuticals SA Female Contraception Drug Revenue Global Market Share (2012-2017)
Table Orbis Biosciences Inc Basic Information List
Table Orbis Biosciences Inc Female Contraception Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Orbis Biosciences Inc Female Contraception Drug Sales Growth Rate (2012-2017)
Figure Orbis Biosciences Inc Female Contraception Drug Sales Global Market Share (2012-2017
Figure Orbis Biosciences Inc Female Contraception Drug Revenue Global Market Share (2012-2017)
Table Teva Pharmaceutical Industries Ltd Basic Information List
Table Teva Pharmaceutical Industries Ltd Female Contraception Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Teva Pharmaceutical Industries Ltd Female Contraception Drug Sales Growth Rate (2012-2017)
Figure Teva Pharmaceutical Industries Ltd Female Contraception Drug Sales Global Market Share (2012-2017
Figure Teva Pharmaceutical Industries Ltd Female Contraception Drug Revenue Global Market Share (2012-2017)
Table Viramal Ltd Basic Information List
Table Viramal Ltd Female Contraception Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Viramal Ltd Female Contraception Drug Sales Growth Rate (2012-2017)
Figure Viramal Ltd Female Contraception Drug Sales Global Market Share (2012-2017
Figure Viramal Ltd Female Contraception Drug Revenue Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Female Contraception Drug
Figure Manufacturing Process Analysis of Female Contraception Drug
Figure Female Contraception Drug Industrial Chain Analysis
Table Raw Materials Sources of Female Contraception Drug Major Players in 2016
Table Major Buyers of Female Contraception Drug
Table Distributors/Traders List
Figure Global Female Contraception Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Global Female Contraception Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Female Contraception Drug Price (USD/Pcs) and Trend Forecast (2017-2022)
Table Global Female Contraception Drug Sales Volume (K Pcs) Forecast by Regions (2017-2022)
Figure Global Female Contraception Drug Sales Volume Market Share Forecast by Regions (2017-2022)
Figure Global Female Contraception Drug Sales Volume Market Share Forecast by Regions in 2022
Table Global Female Contraception Drug Revenue (Million USD) Forecast by Regions (2017-2022)
Figure Global Female Contraception Drug Revenue Market Share Forecast by Regions (2017-2022)
Figure Global Female Contraception Drug Revenue Market Share Forecast by Regions in 2022
Figure United States Female Contraception Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Female Contraception Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Female Contraception Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure China Female Contraception Drug Revenue and Growth Rate Forecast (2017-2022)
Figure Europe Female Contraception Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Europe Female Contraception Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Female Contraception Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Japan Female Contraception Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Female Contraception Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Female Contraception Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Female Contraception Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure India Female Contraception Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Global Female Contraception Drug Sales (K Pcs) Forecast by Type (2017-2022)
Figure Global Female Contraception Drug Sales Volume Market Share Forecast by Type (2017-2022)
Table Global Female Contraception Drug Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Female Contraception Drug Revenue Market Share Forecast by Type (2017-2022)
Table Global Female Contraception Drug Price (USD/Pcs) Forecast by Type (2017-2022)
Table Global Female Contraception Drug Sales (K Pcs) Forecast by Application (2017-2022)
Figure Global Female Contraception Drug Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【レポートのキーワード】

女性用避妊薬

★調査レポート[世界の女性用避妊薬市場:販売動向2018] (コード:QYR8020660)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の女性用避妊薬市場:販売動向2018]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆